ASXRAD (ASXRAD) News
Follow ASXRAD (ASXRAD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Radiopharm Theranostics Receives AU$5.9 Million R&D Tax Refund for Fiscal Year 2025
() -- Radiopharm Theranostics (ASX:RAD) received its research and development (R&D) tax refund for the fiscal year 2025, totalling AU$5.9 million, including AU$104,475 in interest, according to a Friday Australian bourse
EQUITY | Jul 03, 2026, 06:40 AM UTC
L
Starpharma Says Radiopharm Theranostics Collaboration Milestone Triggers AU$500,000 Option Fee
() -- Starpharma Holdings (ASX:SPL) achieved a milestone under its collaboration with Radiopharm Theranostics (ASX:RAD), triggering an AU$500,000 option fee payable to Starpharma, according to a Friday filing with the Au
EQUITY | Jul 03, 2026, 01:12 AM UTC